How Digital Diagnostics Are Changing Healthcare

How Digital Diagnostics Are Changing Healthcare

  • On October 1, 2019
The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.
Read More
Ellume shines at AFR BOSS’ Most Innovative Companies Awards

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

  • On August 12, 2019
We’re excited to announce Ellume was recognised as one of Australia and New Zealand’s Most Innovative Companies in 2019, ranking #2 on the Health and Pharmaceutical list published by The Australian Financial Review and Boss Magazine. The prestigious annual list is based on a rigorous  assessment process managed by Australia’s leading innovation consultancy, Inventium, in […]
Read More
The 10 most innovative health companies

The 10 most innovative health companies

  • On August 9, 2019
The AFR BOSS Most Innovative Companies list recognises the most innovative organisations in Australia and New Zealand, as judged by the expert panel assembled by The Australian Financial Review and Inventium.
Read More
Ellume Appoints CFO And CBO

Ellume Appoints CFO And CBO

  • On April 23, 2019
Brisbane, Australia – 23rd April 2019 Ellume Limited (Ellume) is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company. These appointments strengthen the management of the company in preparation for US commercialisation and potential ASX IPO later this year. David […]
Read More
Ellume announces another global partnership – this time with QIAGEN on the detection of tuberculosis

Ellume announces another global partnership – this time with QIAGEN on the detection of tuberculosis

  • On January 8, 2019
Highlights Australia’s Ellume Limited has partnered with QIAGEN N.V. to bring the next generation of latent TB testing to low-resource, high-burden countries The deal includes the licensing of Ellume technologies and a USD $15M minority investment by QIAGEN in Ellume Limited This announcement builds on the recent announcement of a global partnership with GlaxoSmithKline announced […]
Read More
Medical diagnostics firm Ellume gets German backing for TB testing

Medical diagnostics firm Ellume gets German backing for TB testing

  • On January 7, 2019
7 January 2019, Peter Williams This article originally appeared in The Australian, print and online, on 7th January 2019. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has received a $US15 million ($21m) investment from German biotech Qiagen as part of a broader strategic partnership between the two companies to detect tuberculosis. Clinical trials for a […]
Read More